ELISA Assay of Serum Soluble CD22 To Assess Tumor Burden/Relapse In Patients With B-Cell Leukemia And Lymphoma
Technology
E-065-2002
Patent ID
E-065-2002-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
60/382,269
IC
NCI
Date Filed
Date Issued
Patent PDF